跳至主要内容
临床试验/NCT04411823
NCT04411823招募中不适用

Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
200
试验地点
2
主要终点
Worsening or new-onset gastroesophageal reflux disease

研究概览

简要总结

Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.

详细描述

Subjects will undergo an upper endoscopy with EndoFLIP before sleeve gastrectomy to measure parameters from endoscopy and EndoFLIP device to develop a prediction model for post-operative gastroesophageal reflux disease. Subjects will undergo a repeat upper endoscopy with EndoFLIP at 6 months if an upper endoscopy is clinically indicated after surgery and complete questionnaires during follow-ups up to 5 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients > 18 years
  • BMI 30 or greater kg/m2
  • Participants can give a consent to the procedure
  • Participants have no contraindications to LSG (gastric ulceration)

排除标准

  • Participants who have LA grade C or D esophagitis, Barrett mucosa or peptic stricture.
  • Patients who have evidence of a major motility abnormality defined by the Chicago classification version 3.0 (achalasia, absent contractility, esophagogastric junction outflow obstruction, distal esophageal spasm, or hypertensive peristalsis)
  • Patients with hiatal hernia > 3 cm
  • Patients with previous esophageal or stomach surgery

研究组 & 干预措施

Intervention arm

Experimental

Undergo an upper endoscopy with EndoFLIP at baseline before sleeve gastrectomy

干预措施: EndoFLIP measurement (Device)

结局指标

主要结局

Worsening or new-onset gastroesophageal reflux disease

时间窗: Baseline, 6 months, and 5 years

Determined by the change in the GERD-Health Related Quality of Life questionnaire score with questions individually scored on a scale of 0-5, combined to determine a total score range of 0-75 where a higher score indicates worse quality of life and increased score would indicate new or worsening GERD.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Omar Ghanem

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

Post-sleeve Gastrectomy Gastroesophageal Reflux... | 临床试验